Overview
This study investigates if longitudinal analyses of cell-free HPV-DNA in blood samples can be utilized to detect recurrence in patients diagnosed and treated for HPV-positive oropharyngeal squamous cell carcinoma.
Eligibility
Inclusion Criteria:
- Patients with newly diagnosed HPV+ (or p16+) OPSCC carcinoma originating from the oropharynx
- Above 18 years of age
- Informed consent
- Patients offered curative treatment.
Exclusion Criteria:
- The patient does not speak or understand Danish
- The patient has another disease/condition considered a reason for exclusion